KabackMMNathanTJGreenwaldS. Tay-Sachs disease: Hcterozygott screening and prenatal diagnosis—US experience and world perspective. In: KabackMM, ed. Tay-Sachs disease: Screening and prevention., New York: Alan R Liss, 1977:13–36.
2.
ModellBBerdoukasV. The clinical approach to thalassaemia., London: Grune and Stratten, 1984:354–78.
3.
BowmanJE.Prenatal screening for haemoglobinopathies. Am J Hum Genet, 1991;48:433–8.
4.
RiordanJRRommensJMKeremBIdentification of the cystic fibrosis gene: Cloning and characterisation of complementary DNA. Science, 1989;245:1066–73.
5.
ShrimptonAEMcIntoshIBrockDJH.The incidence of different cystic fibrosis mutations in the Scottish population. J Med Genet, 1991;28:317–21.
6.
WilfondBSFostN. The cystic fibrosis gene: Medical and social implications for heterozygote detection. JAMA, 1990;263:2778–83.
7.
GilbertF. Is population screening for cystic fibrosis appropriate now?Am J Hum Genet1990;46:394–5.
8.
Ten KateLPCarrier screening in CF. Nature, 1989;342:131.
9.
Workshop on population screening for the cystic fibrosis gene. Statement from the National Institutes of Health Workshop on population screening for the cystic fibrosis gene. N Engl J Med, 1990;323:70–1.
BrockDJH.Population screening for cystic fibrosis. Am J Hum Genet, 1990;47:164–5.
12.
SchulmanJDMaddalenaABlackSHBickDP.Screening for cystic fibrosis carriers. Am J Hum Genet, 1990;47:740.
13.
RanieriERyallRGMorrisCPNeonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct analysis. BMJ, 1991;302:1237–10.
14.
ZeesmanSClowCLCartierLScriverCR.A private view of heterozygosity: Eight year follow up study of carriers of the Tay-Sachs gene detected by high-school screening in Montreal. Am J Med Genet, 1984;18:769–78.
15.
ScriverCRBardanisMCartierLβ-Thalassaemia disease prevention: Genetic medicine applied. Am J Hum Genet, 1984;35:1024–38.
16.
WatsonEKMayallEChappellJScreening for carriers of cystic fibrosis through primary health care services. BMJ, 1991;303:504–7.
17.
BekkerHModellMDennissGUptake of cystic fibrosis testing in primary care: Supply, push or demand pull?BMJ1993;306:1584–6.
18.
BrockDJHShrimptonAEJonesCMcIntoshI. Cystic fibrosis: The new genetics. J R Soc Med, 1991;84(suppl 18):2–9.
19.
WaldNJ.Couple screening for cystic fibrosis. Lancet, 1991;338:1318–19.
20.
MennieMEGilfillanAComptonMPrenatal screening for cystic fibrosis. Lancet, 1992;340:214–6.
21.
MennieMEListonWABrockDJH.Prenatal cystic fibrosis carrier testing: Designing an information leaflet to meet the specific needs of the target population. J Med Genet, 1992;29:308–12.
22.
SchwartzMBrandtNJSkovbyF. Screening for carriers of cystic fibrosis among pregnant women; a pilot study. Eur J Hum Genet, 1993;1:239–44.
23.
LivingstoneJAxtonRAMennieMGilfillanABrockDJH.A preliminary trial of couple screening for cystic fibrosis: Designing an appropriate information leaflet. Clin Genet, 1993;43:57–62.
24.
WaldNJGeorgeLMWaldNMMacKenzieIZ.Couple screening for cystic fibrosis. Lancet, 1993;342:1307–8.
25.
HarrisHScotcherDHartlieNCystic fibrosis carrier testing in early pregnancy by general practitioners. BMJ, 1993;306:1580–3.
26.
BrambatiBTuluiLFattpreSFerecC. First-trimester fetal screening of cystic fibrosis in low-risk population. Lancet, 1993;342:624.
27.
BlackSHBickDBMaddalenaAPregnancy screening for cystic fibrosis. Lancet, 1993;342:1112–13.
28.
SuperMSchwarzMJMaloneG. Screening for cystic fibrosis carriers. Lancet, 1992;340:490–1.
29.
MarteauTM.Psychological costs of screening. BMJ, 1989;299:527.
30.
McQueenDV.Social aspects of genetic screening for Tay-Sachs disease; the pilot community screening programme in Baltimore and Washington. Soc Biol, 1975;22:125–33.
31.
WatsonEKMayallESLambJChappellJWilliamsonR. Psychological and social consequences of community carrier screening programme for cystic fibrosis. Lancet, 1992;340:217–20.
32.
MennieMEComptonMEGilfillanAPrenatal screening for cystic fibrosis psychological effects on carriers and their partners. J Med Genet, 1993;30:543–8.
33.
MennieMGilfillanAComptonMEListonWBrockDJH.Prenatal cystic fibrosis carrier screening: Factors in a woman's decision to decline testing. Prenat Diagn, 1993;13:807–14.
34.
MennieMEComptonMEGilfillanAPrenatal screening for cystic fibrosis: Attitudes and responses of participants. Clin Genet, 1993;44:102–6.